AMGN

NASDAQ · Biotechnology

Amgen Inc

S&P 500 Nasdaq 100 Dow Jones Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks

$362.12

+1.57 (+0.44%)

As of Jun 30, 9:30 PM ET ·

Financial Highlights (FY 2026)

Revenue

36.54B

Net Income

7.67B

Gross Margin

70.8%

Profit Margin

21.0%

Rev Growth

+11.8%

D/E Ratio

6.31

Revenue & Net Income

Margin Trends

	FY 2026	FY 2025	FY 2024	FY 2023
Gross Margin	70.8%	70.8%	50.3%	50.3%
Operating Margin	25.4%	22.9%	1.8%	2.2%
Profit Margin	21.0%	19.9%	1.5%	1.7%

Income Statement

	FY 2026	FY 2025	FY 2024	FY 2023
Revenue	36.54B	32.69B	561.58B	538.84B
Gross Profit	25.86B	23.14B	282.31B	270.88B
Operating Income	9.29B	7.48B	10.30B	11.85B
Net Income	7.67B	6.17B	8.50B	9.25B
Gross Margin	70.8%	70.8%	50.3%	50.3%
Operating Margin	25.4%	22.9%	1.8%	2.2%
Profit Margin	21.0%	19.9%	1.5%	1.7%
Rev Growth	+11.8%	+11.8%	+24.6%	+7.7%

Balance Sheet

	FY 2026	FY 2025	FY 2024	FY 2023
Total Debt	83.34B	83.34B	59.25B	55.06B
Total Equity	13.21B	13.21B	120.16B	131.87B
D/E Ratio	6.31	6.31	0.49	0.42

Cash Flow

	FY 2026	FY 2025	FY 2024	FY 2023
EBITDA	14.43B	12.26B	18.36B	16.26B
Free Cash Flow	—	—	5.30B	5.02B